Finn Patrick John 4

What Happened

• Finn Patrick John, President and COO of Twist Bioscience (TWST), reported a sale of 2,321 shares on 2026-04-23 at $60.76 per share, totaling roughly $141,026. The sale was reported on a Form 4 filed 2026-04-27.
• Per the filing footnote, this sale represents a "sell-to-cover" transaction to satisfy tax withholding on vested Restricted Stock Units (RSUs). These are mandated by the company’s equity plan and are not discretionary trades by the insider.

Key Details

• Transaction date: 2026-04-23; Price: $60.76 per share; Total proceeds: ~$141,026
• Transaction type/code: Sale (S); reason: tax withholding on RSU vesting (see footnote F1)
• Shares owned after transaction: Not specified in the provided filing excerpt
• Filing date: 2026-04-27 — filed within the typical 2-business-day window (timely)
• Footnote F1: Sale required by issuer election to fund tax withholding ("sell to cover"); not an independent trading decision

Context

• Sell-to-cover transactions are common when RSUs vest; they’re used solely to pay required taxes and generally don’t signal the insider’s view on the company’s stock. This routine withholding sale is typically less informative than voluntary open-market purchases.